Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Change in Acquisitions & Divestments (2021 - 2023)

iBio (IBIO) has disclosed Change in Acquisitions & Divestments for 3 consecutive years, with -$799000.0 as the latest value for Q1 2023.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 85.5% to -$799000.0 in Q1 2023 year-over-year; TTM through Jun 2023 was $4.1 million, a 69.89% decrease, with the full-year FY2023 number at $4.1 million, down 69.89% from a year prior.
  • Change in Acquisitions & Divestments was -$799000.0 for Q1 2023 at iBio, down from $1.7 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $13.6 million in Q2 2022 to a low of -$5.5 million in Q1 2022.
  • A 3-year average of $2.4 million and a median of $2.4 million in 2021 define the central range for Change in Acquisitions & Divestments.
  • Biggest YoY gain for Change in Acquisitions & Divestments was 444.72% in 2022; the steepest drop was 467.4% in 2022.
  • iBio's Change in Acquisitions & Divestments stood at $3.1 million in 2021, then plummeted by 45.39% to $1.7 million in 2022, then plummeted by 147.03% to -$799000.0 in 2023.
  • Per Business Quant, the three most recent readings for IBIO's Change in Acquisitions & Divestments are -$799000.0 (Q1 2023), $1.7 million (Q4 2022), and $3.2 million (Q3 2022).